L 674573
CAS No. 127481-29-2
L 674573( L-674573 | L674573 | L-674,573 | L 674,573 | L674,573 )
Catalog No. M27775 CAS No. 127481-29-2
L 674573 is an inhibitor of leukotriene biosynthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 71 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 71 | In Stock |
|
| 25MG | 122 | In Stock |
|
| 50MG | 179 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL 674573
-
NoteResearch use only, not for human use.
-
Brief DescriptionL 674573 is an inhibitor of leukotriene biosynthesis.
-
DescriptionL 674573 is an inhibitor of leukotriene biosynthesis.(In Vitro):L-674,573 specifically inhibits labeling of an 18-kDa protein, in a concentration dependent manner with IC50 of 70nM .
-
In Vitro——
-
In Vivo——
-
SynonymsL-674573 | L674573 | L-674,573 | L 674,573 | L674,573
-
PathwayGPCR/G Protein
-
TargetLeukotriene Receptor
-
RecptorHIF-PH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number127481-29-2
-
Formula Weight457.59
-
Molecular FormulaC28H27NO3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CSC(CCCc1ccccc1)c1ccc(OCc2ccc3ccccc3n2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Natalya A Smirnova, et, al. Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation. Chem Biol. 2010 Apr 23;17(4):380-91.
molnova catalog
related products
-
SR 2640 hydrochlorid...
SR 2640 hydrochloride is a competitive antagonist of leukotriene D4 and E4 and can be used in studies about leukotrienes in human asthma.
-
Zafirlukast
A potent, selective, orally active leukotriene D4 (LTD4) receptor antagonist antagonist for the maintenance treatment of asthma.
-
Gemilukast
Gemilukast (ONO-6950, ONO6950) is a potent, orally active, dual CysLT1 and CysLT2 antagonist with IC50 of 1.7 and 25 nM against human CysLT1 and human CysLT2, respectively.
Cart
sales@molnova.com